Literature DB >> 11384747

Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells.

A J Johnson1, X song, A Hsu, C Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11384747     DOI： 10.1016/s0065-2571(00)00015-7

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  12 in total

1.  Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.

Authors:  Jason R Gee; Corrie B Burmeister; Thomas C Havighurst; Kyungmann Kim
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

2.  From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

Authors:  Bo Zhong; Xiaohan Cai; Snigdha Chennamaneni; Xin Yi; Lili Liu; John J Pink; Afshin Dowlati; Yan Xu; Aimin Zhou; Bin Su
Journal:  Eur J Med Chem       Date:  2011-11-15       Impact factor: 6.514

3.  A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth.

Authors:  Junan Li; Jiuxiang Zhu; W Scott Melvin; Tanios S Bekaii-Saab; Ching-Shih Chen; Peter Muscarella
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

4.  Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target.

Authors:  Su-Hyeong Kim; Sang-Hyun Song; Sang-Gyun Kim; Kyung-Soo Chun; So-Young Lim; Hye-Kyung Na; Jae Weon Kim; Young-Joon Surh; Yung-Jue Bang; Yong-Sang Song
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-10       Impact factor: 4.553

5.  The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.

Authors:  Amy J Johnson; Ao-Lin Hsu; Ho-Pi Lin; Xueqin Song; Ching-Shih Chen
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

6.  Inhibition of human neuroblastoma in SCID mice by low-dose of selective Cox-2 inhibitor nimesulide.

Authors:  Bhupesh Parashar; Bridget Shafit-Zagardo
Journal:  J Neurooncol       Date:  2006-03-22       Impact factor: 4.130

7.  PDE5 inhibitors enhance celecoxib killing in multiple tumor types.

Authors:  Laurence Booth; Jane L Roberts; Nichola Cruickshanks; Seyedmehrad Tavallai; Timothy Webb; Peter Samuel; Adam Conley; Brittany Binion; Harold F Young; Andrew Poklepovic; Sarah Spiegel; Paul Dent
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

Review 8.  Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

Authors:  G Aparicio Gallego; S Díaz Prado; P Jiménez Fonseca; R García Campelo; J Cassinello Espinosa; L M Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

9.  Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.

Authors:  Peter Pyrko; Nathaniel Soriano; Adel Kardosh; Yen-Ting Liu; Jasim Uddin; Nicos A Petasis; Florence M Hofman; Ching-Shih Chen; Thomas C Chen; Axel H Schönthal
Journal:  Mol Cancer       Date:  2006-05-18       Impact factor: 27.401

Review 10.  Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy.

Authors:  P Ricchi; R Zarrilli; A Di Palma; A M Acquaviva
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.